Your browser doesn't support javascript.
Hospital at Home for Elderly COVID-19 Patients: A Preliminary Report with 100 Patients.
Miyamoto, Yuki; Matsuyama, Tasuku; Kunimitsu, Katsutomo; Nagano, Hiroyuki; Yamada, Yoshie; Murakami, Shigemi; Yamahata, Yoshihiro; Ohta, Bon; Morikami, Yoshiki; Nakagawa, Masanori.
  • Miyamoto Y; Department of Emergency and Disaster Medical Systems, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
  • Matsuyama T; Yoshiki Home Care Clinic, Kyoto 6158262, Japan.
  • Kunimitsu K; Department of Emergency and Disaster Medical Systems, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
  • Nagano H; Department of Emergency and Disaster Medical Systems, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
  • Yamada Y; Yoshiki Home Care Clinic, Kyoto 6158262, Japan.
  • Murakami S; Yoshiki Home Care Clinic, Kyoto 6158262, Japan.
  • Yamahata Y; Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Kyoto 6068501, Japan.
  • Ohta B; Yoshiki Home Care Clinic, Kyoto 6158262, Japan.
  • Morikami Y; Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 6068501, Japan.
  • Nakagawa M; Watanabe Nishigamo Home Care Clinic, Kyoto 6038832, Japan.
J Clin Med ; 11(7)2022 Mar 26.
Article in English | MEDLINE | ID: covidwho-2216396
ABSTRACT
Hospital-at-home (HaH) care is useful for patients with COVID-19 and an alternative strategy when hospital capacity is under pressure due to patient surges. However, the efficacy and safety of HaH in elderly patients with COVID-19 remain unknown. In Kyoto city, we conducted a retrospective medical record review of HaH care focused on elderly COVID-19 patients from 4 February to 25 June 2021. Eligible patients were (1) COVID-19 patients aged ≥70 years and those who lived with them or (2) COVID-19 patients aged <70 years with special circumstances and those who lived with them. During the study period, 100 patients received HaH care. Their median age was 76 years (interquartile range 56-83), and 65% were over 70 years. Among 100 patients, 36 (36%) had hypoxia (oxygen saturation ≤ 92%), 21 (21%) received steroid medication, and 34 (34%) received intravenous fluids. Although 22 patients were admitted to the hospital and 3 patients died there, no patients died during HaH care. HaH care may be safe and effective in elderly patients with COVID-19. Our study shows that HaH provides an alternative strategy for treating COVID-19 patients and can reduce the healthcare burden at hospitals.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11071850

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11071850